UPSA Fervex Adultes medicinal powder

Fervex is a well-known pharmaceutical brand specialized in treating symptoms of the common cold, rhinitis, and flu-like conditions. It typically contains a combination of paracetamol, pheniramine, and Vitamin C.

Originally developed in France by Laboratoires UPSA (Union de Pharmacologie Scientifique Appliquée), the brand has remained a staple in European pharmacies for decades. The manufacturing is primarily centered at the UPSA production sites in Agen, France, which serves as a global hub for their effervescent and powdered medicinal products.

In terms of ownership, UPSA was owned by Bristol-Myers Squibb for several years before being acquired by the Taisho Pharmaceutical Group in 2019. Taisho Pharmaceutical is a major Japanese pharmaceutical entity that has expanded its footprint in the European over-the-counter (OTC) market through this strategic acquisition.